Correlation Between Pharmaceuticals Ultrasector and Technology Ultrasector

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Ultrasector and Technology Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Ultrasector and Technology Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmaceuticals Ultrasector Profund and Technology Ultrasector Profund, you can compare the effects of market volatilities on Pharmaceuticals Ultrasector and Technology Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Ultrasector with a short position of Technology Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Ultrasector and Technology Ultrasector.

Diversification Opportunities for Pharmaceuticals Ultrasector and Technology Ultrasector

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pharmaceuticals and Technology is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and Technology Ultrasector Profund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Technology Ultrasector and Pharmaceuticals Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Ultrasector Profund are associated (or correlated) with Technology Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Technology Ultrasector has no effect on the direction of Pharmaceuticals Ultrasector i.e., Pharmaceuticals Ultrasector and Technology Ultrasector go up and down completely randomly.

Pair Corralation between Pharmaceuticals Ultrasector and Technology Ultrasector

Assuming the 90 days horizon Pharmaceuticals Ultrasector Profund is expected to generate 0.66 times more return on investment than Technology Ultrasector. However, Pharmaceuticals Ultrasector Profund is 1.52 times less risky than Technology Ultrasector. It trades about 0.09 of its potential returns per unit of risk. Technology Ultrasector Profund is currently generating about 0.06 per unit of risk. If you would invest  2,337  in Pharmaceuticals Ultrasector Profund on September 3, 2024 and sell it today you would earn a total of  448.00  from holding Pharmaceuticals Ultrasector Profund or generate 19.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pharmaceuticals Ultrasector Pr  vs.  Technology Ultrasector Profund

 Performance 
       Timeline  
Pharmaceuticals Ultrasector 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmaceuticals Ultrasector Profund are ranked lower than 6 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Pharmaceuticals Ultrasector may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Technology Ultrasector 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Technology Ultrasector Profund are ranked lower than 9 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Technology Ultrasector showed solid returns over the last few months and may actually be approaching a breakup point.

Pharmaceuticals Ultrasector and Technology Ultrasector Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharmaceuticals Ultrasector and Technology Ultrasector

The main advantage of trading using opposite Pharmaceuticals Ultrasector and Technology Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Ultrasector position performs unexpectedly, Technology Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Technology Ultrasector will offset losses from the drop in Technology Ultrasector's long position.
The idea behind Pharmaceuticals Ultrasector Profund and Technology Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.